Last reviewed · How we verify
Fonazine (dimetotiazine)
Fonazine (generic name: dimetotiazine) is a dimetotiazine drug. It is currently in unknown development.
Fonazine is thought to work by interacting with a specific target in the body, although the exact mechanism is not well understood.
Fonazine, also known as dimetotiazine, is a small molecule drug of the dimetotiazine class. Its target and exact mechanism of action are unknown. It is not FDA-approved for any indications. The commercial status of Fonazine, including whether it is patented or generic, and whether it is off-patent, is also unknown. Further research is needed to determine its safety and efficacy.
At a glance
| Generic name | dimetotiazine |
|---|---|
| Drug class | dimetotiazine |
| Therapeutic area | Other |
| Phase | unknown |
Mechanism of action
Imagine your body's cells are like locks, and Fonazine is a key that fits into one of those locks. When it binds to the lock, it can affect how the cell works, but we don't know exactly how it does that yet. More research is needed to understand how Fonazine works at a molecular level.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Fonazine CI brief — competitive landscape report
- Fonazine updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Fonazine
What is Fonazine?
How does Fonazine work?
What is the generic name of Fonazine?
What drug class is Fonazine in?
What development phase is Fonazine in?
Related
- Drug class: All dimetotiazine drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing